4 ms·
A number of reasons thats wouldn’t help anything: 1) there’s going to be a ton of point of care tests, in fact there already are. The bottleneck is FDA approva
by rubidium 7y ago
A number of reasons thats wouldn’t help anything:
1) there’s going to be a ton of point of care tests, in fact there already are. The bottleneck is FDA approval.
2) scaling up manufacturing of a device like this is HARD. It’s not some raspberry pi hobby kit.
This company is owned by Danaher, a fortune 200 or so which has many engineers and manufacturing sites. They’ll figure out a way to make as many as are needed.